Skip to main
INGN
INGN logo

Inogen (INGN) Stock Forecast & Price Target

Inogen (INGN) Analyst Ratings

Based on 6 analyst ratings
Hold
Strong Buy 17%
Buy 33%
Hold 33%
Sell 17%
Strong Sell 0%

Bulls say

Inogen Inc. demonstrated significant improvement in its financial performance, with an adjusted EBITDA margin increasing by 1,850 basis points year-over-year to (4.4%) and an operating margin rising by 2,400 basis points to (14.2%), surpassing consensus expectations. The company's business-to-business (B2B) sales experienced robust growth of 28.1% year-over-year, reaching $50.7 million, driven by new customer acquisitions and increased orders from existing clients, which indicates a strengthening market position. Additionally, the gross margin showed a positive movement, climbing 820 basis points year-over-year to 45.3%, further emphasizing Inogen's improving profitability metrics and operational efficiency.

Bears say

Inogen Inc faces significant risks, including slower-than-expected revenue growth, deteriorating margins, and ongoing supply chain challenges, which contribute to an overall negative outlook. In the most recent period, direct-to-consumer (DTC) sales experienced a notable decline of 21.3%, negatively impacting revenue and resulting in lowered adjusted EBITDA estimates for 2025 and 2026. Additionally, the company's bear case scenario suggests potential stagnation or modest decline in revenue over the next few years, further exacerbating concerns regarding financial performance and market competitiveness.

Inogen (INGN) has been analyzed by 6 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inogen and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inogen (INGN) Forecast

Analysts have given Inogen (INGN) a Hold based on their latest research and market trends.

According to 6 analysts, Inogen (INGN) has a Hold consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $31.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $31.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inogen (INGN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.